ADAM-17: a novel therapeutic target for triple negative breast cancer.
McGowan PM, Mullooly M, Caiazza F, Sukor S, Madden SF, Maguire AA, Pierce A, McDermott EW, Crown J, O'Donovan N, Duffy MJ.
McGowan PM, et al.
Ann Oncol. 2013 Feb;24(2):362-369. doi: 10.1093/annonc/mds279. Epub 2012 Sep 11.
Ann Oncol. 2013.
PMID: 22967992
Free article.